FR2752423B1 - Procede de preparation d'une forme cristalline therapeutiquement active du sulfate de glucosamine et sulfate de glucosamine ainsi obtenu - Google Patents

Procede de preparation d'une forme cristalline therapeutiquement active du sulfate de glucosamine et sulfate de glucosamine ainsi obtenu

Info

Publication number
FR2752423B1
FR2752423B1 FR9710326A FR9710326A FR2752423B1 FR 2752423 B1 FR2752423 B1 FR 2752423B1 FR 9710326 A FR9710326 A FR 9710326A FR 9710326 A FR9710326 A FR 9710326A FR 2752423 B1 FR2752423 B1 FR 2752423B1
Authority
FR
France
Prior art keywords
glucosamine sulfate
preparation
crystalline form
therapeutically active
active crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9710326A
Other languages
English (en)
Other versions
FR2752423A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm BV succursale di Lugano
Rottapharm BV
Original Assignee
Rotta Research Amsterdam Swiss Branch BV
Rotta Research BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Amsterdam Swiss Branch BV, Rotta Research BV filed Critical Rotta Research Amsterdam Swiss Branch BV
Publication of FR2752423A1 publication Critical patent/FR2752423A1/fr
Application granted granted Critical
Publication of FR2752423B1 publication Critical patent/FR2752423B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR9710326A 1996-08-19 1997-08-13 Procede de preparation d'une forme cristalline therapeutiquement active du sulfate de glucosamine et sulfate de glucosamine ainsi obtenu Expired - Lifetime FR2752423B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH02024/96A CH690719A5 (it) 1996-08-19 1996-08-19 Procedimento per la preparazione di sali misti della glucosamina.

Publications (2)

Publication Number Publication Date
FR2752423A1 FR2752423A1 (fr) 1998-02-20
FR2752423B1 true FR2752423B1 (fr) 2000-03-17

Family

ID=4224138

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9710326A Expired - Lifetime FR2752423B1 (fr) 1996-08-19 1997-08-13 Procede de preparation d'une forme cristalline therapeutiquement active du sulfate de glucosamine et sulfate de glucosamine ainsi obtenu

Country Status (13)

Country Link
US (1) US5847107A (fr)
JP (1) JP4177471B2 (fr)
AT (1) AT408884B (fr)
BE (1) BE1011326A5 (fr)
CA (1) CA2212129C (fr)
CH (1) CH690719A5 (fr)
ES (1) ES2131014B1 (fr)
FR (1) FR2752423B1 (fr)
GB (1) GB2321056B (fr)
GR (1) GR1003096B (fr)
IE (1) IE970547A1 (fr)
NL (1) NL1006790C2 (fr)
PT (1) PT102043B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100381386B1 (ko) * 2000-07-28 2003-04-23 주식회사 효성 디-글루코사민의 제조 방법
EA006632B1 (ru) * 2000-12-01 2006-02-24 Николас Пирамал Индиа Лимитед Кристаллические соли металл-глюкозамин сульфата и способы их приготовления
LT5148B (lt) 2000-12-01 2004-07-26 Nicholas Piramal India Limited Kristalinės gliukozamino sulfato metalų druskos ir jų gavimo būdas
ITMI20012818A1 (it) 2001-12-28 2003-06-28 Acraf Un metodo per preparare un composto della glucosammina e composto cosi ottenuto
JP2010059090A (ja) * 2008-09-03 2010-03-18 Masao Kikuchi グルコサミン誘導体の製造方法
CN101735283B (zh) * 2008-11-14 2012-07-18 徐州海吉亚生物制品有限公司 一种氨基葡萄糖盐酸盐与氨基葡萄糖硫酸钾/钠盐的共结晶技术
CN102485734A (zh) * 2010-12-06 2012-06-06 张治平 一种用于增加骨密度的化合物及其合成方法
CN106749437B (zh) * 2015-11-20 2019-09-20 广东先强药业有限公司 一种硫酸氨基葡萄糖氯化钠复盐母液的回收方法
CN110305176B (zh) * 2019-06-28 2020-10-09 山东润德生物科技有限公司 一种提高氨基葡萄糖盐酸盐热稳定性的制备方法
WO2021167957A1 (fr) * 2020-02-20 2021-08-26 Dianomi Therapeutics, Inc. Revêtements inorganiques pour la libération prolongée de composés bioactifs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2101585A (en) * 1936-04-09 1937-12-07 Waterbury Buckle Company Belt buckle
FR2573M (fr) * 1963-01-18 1964-06-01 Rotta Res Lab Nouveaux médicaments a activité anti-rhumatismale, anti-arthritique et anti-arthrosique contenant des sels de sucres aminés.
IT1148050B (it) * 1981-04-30 1986-11-26 Rotta Research Lab Composto stabile della glucosamina solfato procedimento per la sua preparazione e composizioni farmaceutiche contenenti tale composto
DE3532081A1 (de) * 1985-09-09 1987-03-12 Orion Yhtymae Oy Mischsalze von glucosaminsulfat und verfahren zu ihrer herstellung
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
CA2035841C (fr) * 1990-02-22 1996-02-13 Harry B. Demopoulos Presentations orales de sulfate de glucosamine stables a l'entreposage et mode de fabrication

Also Published As

Publication number Publication date
FR2752423A1 (fr) 1998-02-20
CA2212129A1 (fr) 1998-02-19
BE1011326A5 (fr) 1999-07-06
JPH1087683A (ja) 1998-04-07
GB2321056A8 (en) 2000-11-13
ES2131014A1 (es) 1999-07-01
CH690719A5 (it) 2000-12-29
PT102043A (pt) 1998-02-27
PT102043B (pt) 2000-01-31
AT408884B (de) 2002-03-25
GR970100308A (el) 1998-04-30
GR1003096B (el) 1999-03-22
ES2131014B1 (es) 2000-02-01
ATA138197A (de) 2001-08-15
NL1006790C2 (nl) 1998-12-15
GB9717546D0 (en) 1997-10-22
IE970547A1 (en) 2000-10-04
GB2321056A (en) 1998-07-15
NL1006790A1 (nl) 1998-02-26
US5847107A (en) 1998-12-08
CA2212129C (fr) 2007-11-06
JP4177471B2 (ja) 2008-11-05
GB2321056B (en) 2000-03-29

Similar Documents

Publication Publication Date Title
DZ1880A1 (fr) Forme posologique d'azithromycine et son procédé de production.
FR2768427B1 (fr) Procede de fabrication d'hexafluorophosphate de lithium
FR2752423B1 (fr) Procede de preparation d'une forme cristalline therapeutiquement active du sulfate de glucosamine et sulfate de glucosamine ainsi obtenu
FR2778661B1 (fr) Procede de preparation d'aminonitrile et de diamine
FR2764883B1 (fr) Procede de fabrication d'hydrofluoroalcanes
MA23179A1 (fr) Procede de preparation d'un monohydrate cristallin d'un spirostanylglycoside
FR2744648B1 (fr) Procede de preparation d'agents tensioactifs
FR2758729B1 (fr) Procede de fabrication d'un surf de neige et surf de neige ainsi obtenu
PL345697A1 (en) Method for the production of n,n'-carbonyl diazoles
FR2733228B1 (fr) Procede d'hydroxycarbonylation du butadiene
FR2715656B1 (fr) Procédé de préparation d'anhydride citraconique.
MA24346A1 (fr) Procede pour la preparation de composes anti-inflammatoires et analgesiques
FR2644161B1 (fr) Procede de preparation d'amides n-arylsubstitues
MA24831A1 (fr) Procede pour la preparation d'acides hydroxamiques
FR2729387B1 (fr) Procede pour la fabrication d'hydroxy-alcoxy-benzophenones
FR2795928B1 (fr) Article pour l'application d'une composition topique et son procede de preparation
FR2799753B1 (fr) Procede perfectionne de fabrication d'anhydrides symetriques
FR2724378B1 (fr) Procede de preparation de l'acide picrique
FI912363A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten -oksopyrrolo/2,3-b/indolietikkahappoestereiden ja -amidien valmistamiseksi
ZA953682B (en) Process for the manufacture of Form 1 ranitidine hydrochloride
FR2778651B1 (fr) Procede de transformation de sulfate de fer heptahydrate en sulfate de fer monohydrate dit "semoule"
FR2757543B1 (fr) Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues
FR2769624B1 (fr) Procede de preparation d'acide carboxylique
FR2737547B1 (fr) Tuyau forme d'au moins deux gaines concentriques
FR2786666B1 (fr) Procede de preparation d'une composition culinaire en forme de saucisse et composition ainsi obtenue

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 20